ASOS Plc (ASC) is a British online fashion and cosmetic retailer with an active presence in the UK, the US and Continental Europe. Apart from being a fashion company, the group calls itself a technology company and is one of the leading fashion stops for 20-somethings locations globally. Around 60% of the products are exclusively sold on its platform, and the company operates its own brand of clothes as well.
On 2nd October 2019, ASOS announced the selection of four independent directors (non-executive), namely Eugenia Ulasewicz, Mai Fyfield, Luke Jensen and Karen Geary.
ASC-Financial highlights for FY19
On 16th October 2019, ASOS Plc announced its results for the fiscal year 2019 period ended 31st August 2019. The company’s revenue was up by 13 per cent (AER basis) to £2,733.5 million in FY19 as against £2,417.3 million in FY18. The company’s retail sales were up by 13 per cent (AER basis) to £2,657.7 million in FY19 as against £2,355.2 million in FY18. The company’s gross profit was up by 8 per cent to £1,334.3 million in FY19 as against £1,237.1 million in FY18. However, the company’s retail gross margin dipped by 250 basis points to 47.4 per cent in FY19 from 49.9 per cent in FY18. Also, the overall gross margin dipped by 240 basis points to 48.8 per cent in FY19 as against 51.2 per cent in FY18. The company’s profit before taxation was down by 68 per cent to £33.1 million in FY19 as against £102 million in FY18. The company’s diluted earnings per share were down by 70 per cent to 29.4 pence in FY19 as against 98 pence in FY18.
ASC-Share price performance
On 16th October 2019, at the time of writing (before the market close, GMT 01:00 PM), Asos Plc shares were trading at GBX 3,057.00, up by 19.41 per cent against its previous day closing price. Stock's 52 weeks High and Low is GBX 6,153.26/GBX 2,033.00. The outstanding market capitalisation was around £2.12 billion.
Renishaw Plc (RSW) is among the world’s leading engineering and technology company which is specialising in healthcare and precision measurement. The company provides diversified products and services such as jet engines, surgical instruments and wind turbine etc. The company currently operates in 35 countries and have 70 offices with an employee base of 4,000 people worldwide.
RSW-Q1 Trading update FY20
On 15th October 2019, the company released its trading update for the first quarter of the fiscal year 2020 period ended 30th September 2019. The company’s revenue stood at £124.6 million in Q1 FY20 as against £154.0 million in Q1 FY19. The company’s profit before taxation (adjusted) stood at £4.3 million in Q1 FY20 which includes restructuring provisions of £2 million as against £32.6 million in Q1 FY19. The company had net cash balances of £98.5 million at 30th September 2019 as against £106.8 million at 30th June 2019.
RSW-Financial highlights for FY19 period ended 30th June 2019
The company’s revenue was recorded at £574.0 million in the fiscal year 2019. As a result of a slowdown in demand for encoder and machine tool products in the APAC region, the revenue from Metrology plunged by 7 per cent to £532.9 million in FY19. With strong growth in company’s spectroscopy and dental product lines contributed to a 15 per cent rise in Healthcare revenue. The company’s operating profit (adjusted) was recorded at £3.1 million in FY19 as against £0.3 million in FY18. The company’s profit before taxation (adjusted) plunged by 28 per cent to £103.9 million in FY19 as against £145.1 million in FY18. The company’s statutory profit plunged by 29 per cent to £109.9 million in FY19 as against £155.2 million in FY18. The company’s balance sheet was strong with cash of £106.8 million in FY19 as against £103.8 million in FY18. The company proposed a final dividend of 46 pence per share for the fiscal year 2019. The company’s total dividend for the fiscal year 2019 was recorded at 60 pence per share.
RSW-Share price performance
On 16th October 2019, at the time of writing (before the market close, GMT 01:03 PM), Renishaw Plc shares were trading at GBX 3,202, down by 3.43 per cent against its previous day closing price. Stock's 52 weeks High and Low is GBX 4,724.00/GBX 3,030.00. The outstanding market capitalisation was around £2.38 billion with a dividend yield of 1.81 per cent.
Barratt Developments PLC
Barratt Developments PLC (BDEV) is the UK-based company, which is into the development of residential spaces, land acquisition, project planning, plotting, construction and marketing property across Britain.
The company has started well in the new fiscal year. The company senses a strong demand for high- quality new homes across the United Kingdom. In the 15-week period from 1 July to 13 October period, the company has delivered 3,252 home completions (including Joint Ventures), up by 14 per cent from the previous year. The company looks forward to buying land at 23 per cent gross margin and approve 18,000-22,000 plots roughly for purchase in FY20. The board proposed a final dividend of 19.5 pence per share in September along with a special dividend of 17.3 pence per share which would be payable on 5th November 2019.
BDEV-Financial highlights for FY19
Led by solid operational and financial performance reported during the FY19 along with good progress towards the medium-term targets, the group's operating margin improved by 120 basis points to 18.9 per cent against 17.7 per cent reported in the FY18. However, the group's revenue on a YoY basis shrunk by 2.3 per cent to £4,763.1 million from £4,874.8 million recorded in the year-ago period. But, the group's improved performance at the operational level, took the pre-tax profit at £909.8 million against £835.5 million reported in the previous financial year. Also, the group’s decent pre-tax profit growth on a YoY basis benefited from joint ventures. The basic earnings per share during the year under review surged to 73.2 pence per share from 66.5 pence per share reported in FY2018.
BDEV-Share price performance
On 16th October 2019, at the time of writing (before the market close, GMT 01:06 PM), Barratt Developments PLC shares were trading at GBX 674.4, down by 1.25 per cent against its previous day closing price. Stock's 52 weeks High and Low is GBX 702.80/GBX 417.79. The outstanding M-cap (market capitalisation) was around £6.86 billion, with a dividend yield of 4.26 per cent.
Mediclinic International Plc
Mediclinic International Plc (MDC) is a global private healthcare services group. The company was founded in the year 1983 and is headquartered in Stellenbosch, South Africa. The company operates internationally with Switzerland, Namibia, South Africa and the United Arab Emirates being the main markets. Acute-care, specialist-orientated, multi-disciplinary healthcare services are the major service offerings of the company.
MDC-Trading update for H1 FY20
On the constant currency basis, the company’s revenue was up by 6.5 per cent, and EBITDA (pre-IFRS16) was up by 3.5 per cent. On reported basis, the company’s revenue was up by 9 per cent, and EBITDA (pre-IFRS16) was up by 5 per cent.
MDC-Financial highlights for FY19
The company’s revenue was up by 2 per cent to GBP 2,932 million in FY19. The company’s EBITDA (adjusted) was down by 4 per cent to GBP 493 million in FY19 capturing the impact of regulatory changes on Hirslanden. The company’s operating profit (adjusted) was down by 11 per cent to GBP 330 million. The company’s earnings per share (adjusted) was down by 10 per cent to 26.9 pence, in line with market expectations. The company’s cash conversion rate was 91 per cent of adjusted EBITDA in FY19. The company recommended a final dividend of 4.70 pence per share in FY19. The total dividend of the company stood at 7.90 pence per share in FY19.
MDC-Share price performance
On 16th October 2019, at the time of writing (before the market close, GMT 01:08 PM), Mediclinic International Plc shares were trading at GBX 371.1, up by 3.65 per cent against its previous day closing price. Stock's 52 weeks High and Low is GBX 477.50 /GBX 288.30. The outstanding market capitalisation was around £2.60 billion, with a dividend yield of 2.21 per cent.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.